Tango Therapeutics to Present at the Guggenheim SMID Cap Biotechnology Conference
Detailed price information for Tango Therapeutics Inc (TNGX-Q) from The Globe and Mail including charting and trades.
TNGX stock touches 52-week low at $2.58 amid market challenges
In a challenging market environment, TNGX stock has reached a new 52-week low, with shares plummeting to $2.58. According to InvestingPro data, while the company maintains strong liquidity with a ...
What is Leerink Partnrs’ Forecast for TNGX Q3 Earnings?
Equities researchers at Leerink Partnrs issued their Q3 2025 earnings per share (EPS) estimates for Tango Therapeutics in a ...
One Tango Therapeutics Insider Raised Stake By 400% In Previous Year
Looking at Tango Therapeutics, Inc.'s ( NASDAQ:TNGX ) insider transactions over the last year, we can see that ...